Dingcun Luo
Overview
Explore the profile of Dingcun Luo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
47
Citations
105
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Song P, Zhang Q, Xu Z, Shi Y, Jing R, Luo D
Biomark Res
. 2024 May;
12(1):54.
PMID: 38816881
Chimeric antigen receptor T cell (CAR-T) therapy has revolutionized the treatment approach for cancer, autoimmune disease, and heart disease. The integration of CAR into T cells is typically facilitated by...
12.
Wu F, Huang K, Huang X, Pan T, Li Y, Shi J, et al.
Front Endocrinol (Lausanne)
. 2024 Feb;
14:1271446.
PMID: 38415181
Objectives: To explore the preoperative high-risk clinical factors for contralateral medium-volume central lymph node metastasis (conMVCLNM) in unilateral papillary thyroid carcinoma (uPTC) and the indications for dissection of contralateral central...
13.
Zhao L, Hu T, Cai Y, Zhou T, Zhang W, Wu F, et al.
Front Endocrinol (Lausanne)
. 2024 Jan;
14:1254124.
PMID: 38189045
Objective: The aim of this study was to investigate the relationships and predictive value of preoperative peripheral blood inflammatory markers as a means by which to assess risk for patients...
14.
Han H, Fu X, Zhang Y, Luo D, Zhang X, Wu X
Iran J Public Health
. 2023 Nov;
52(9):1902-1916.
PMID: 38033847
Background: N6-methyladenosine (m6A) methylation modification is involved in tumorigenesis and progression and can affect various stages of RNA processing. We aimed to determine m6A methylation modifications on a transcriptome-wide scale...
15.
Li Y, Wu F, Ge W, Zhang Y, Hu Y, Zhao L, et al.
Int J Surg
. 2023 Nov;
110(1):372-384.
PMID: 37916932
Background: Papillary thyroid cancer (PTC) is one of the most common endocrine malignancies with different risk levels. However, preoperative risk assessment of PTC is still a challenge in the worldwide....
16.
Hu T, Zhou T, Zhang Y, Zhou L, Huang X, Cai Y, et al.
J Clin Ultrasound
. 2023 Nov;
52(1):51-58.
PMID: 37915163
Objective: To investigate the efficacy of the ultrasonic nodule to muscle gray scale ratio as a predictive tool for distinguishing between benign and malignant thyroid nodules. Methods: A retrospective study...
17.
Zhou T, Xu L, Shi J, Zhang Y, Lin X, Wang Y, et al.
Eur Radiol
. 2023 Aug;
34(2):1324-1333.
PMID: 37615763
Objectives: Artificial intelligence (AI) systems can diagnose thyroid nodules with similar or better performance than radiologists. Little is known about how this performance compares with that achieved through fine needle...
18.
Zhou T, Hu T, Ni Z, Yao C, Xie Y, Jin H, et al.
Endocrine
. 2023 Aug;
83(1):118-126.
PMID: 37542676
Objective: To investigate the application of machine learning (ML) model-based thyroid ultrasound radiomics in the evaluation of malignancy in partially cystic thyroid nodules (PCTNs). Methods: One hundred and ninety-two patients...
19.
Amanullah M, Pan M, Lu K, Pan X, Lu Y, Luo D, et al.
Curr Oncol
. 2023 Mar;
30(3):2625-2641.
PMID: 36975413
Regional lymph node metastasis (LNM) increases the risk of distant metastasis in papillary thyroid cancer (PTC) patients. However, it remains unclear how tumor cells in PTC patients with LNM evade...
20.
Mao Z, Ding Y, Wen L, Zhang Y, Wu G, You Q, et al.
Front Endocrinol (Lausanne)
. 2023 Feb;
14:1091200.
PMID: 36814578
Background: Preoperative fine-needle aspiration (FNA) is widely used to differentiate malignant from benign thyroid nodules, while intraoperative frozen sections (FS) are suggested as a systematic supplement for intraoperative decision-making, but...